Published :
Tables : 55
Figures : 45
Category : Healthcare
No. of Pages : 200
Report Code : HC-1316
Smart Insulin Pens Market is estimated to value over USD 137 million by 2027 end and register a CAGR of over 10.8% during the forecast period 2020 to 2027. A rise in the presence of diabetic conditions raises the insistence for needle-free insulin delivery devices that are needle-free. As per the Centers for Disease Control and Prevention (CDC), approximately 30 million people or over 9% of the total population of the United States suffered from diabetes in 2015. Additionally, as per the Diabetes UK, in 2017, over 3.2 million people were diabetes patients. Therefore, an increase in diabetes-related conditions is projected to have a positive influence on the smart insulin pens market growth. The Asia Pacific market is predicted to expand the smart insulin pens market size with a high growth rate over the forecast period, owing to a rise in the ageing population who have more chances of getting diagnosed with diabetes. The Asia-Pacific region offers profitable opportunities for market proliferation, owing to its ever-increasing population base and increase in the prevalence of diabetic patients. Additionally, low device costs as compared to traditional insulin pen shall further increase the insistence of smart insulin pens in the Asia Pacific region. Key market players included in smart insulin pens industry are Novo Nordisk, Sanofi, Eli Lilly and Co., Companion Medical, Emperra GmbH E-Health Technologies, Diabnext, Jiangsu Delfu Medical Device Co. Ltd., Berlin Chemie, Diamesco Co. Ltd., Patients Pending Ltd. Smart Insulin Pens Market Market Segmentation: By Product Smart Insulin Pen Adaptors for Conventional Pen By Connectivity Bluetooth USB By Diabetes Type Type 1 Diabetes Type 2 Diabetes By Distribution Channel Hospital Pharmacy Online Sales Retail Pharmacy Diabetes Clinics/Centres By Region North America Europe Asia Pacific Latin America Middle East & Africa FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the market by product, by connectivity, by diabetes type, by distribution channel and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, industry-specific restraints and opportunities) To forecast and evaluate micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa To record, evaluate and analyse competitive landscape mapping- technological advancements, product launches, expansions and mergers
A rise in the presence of diabetic conditions raises the insistence for needle-free insulin delivery devices that are needle-free. As per the Centers for Disease Control and Prevention (CDC), approximately 30 million people or over 9% of the total population of the United States suffered from diabetes in 2015. Additionally, as per the Diabetes UK, in 2017, over 3.2 million people were diabetes patients. Therefore, an increase in diabetes-related conditions is projected to have a positive influence on the smart insulin pens market growth.
The Asia Pacific market is predicted to expand the smart insulin pens market size with a high growth rate over the forecast period, owing to a rise in the ageing population who have more chances of getting diagnosed with diabetes. The Asia-Pacific region offers profitable opportunities for market proliferation, owing to its ever-increasing population base and increase in the prevalence of diabetic patients. Additionally, low device costs as compared to traditional insulin pen shall further increase the insistence of smart insulin pens in the Asia Pacific region.
Key market players included in smart insulin pens industry are Novo Nordisk, Sanofi, Eli Lilly and Co., Companion Medical, Emperra GmbH E-Health Technologies, Diabnext, Jiangsu Delfu Medical Device Co. Ltd., Berlin Chemie, Diamesco Co. Ltd., Patients Pending Ltd.
Smart Insulin Pens Market Market Segmentation:
By Product
By Connectivity
By Diabetes Type
By Distribution Channel
By Region
FutureWise Key Takeaways:
Objectives of the Study:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Smart Insulin Pens Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards And Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Smart Insulin Pens Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Smart Insulin Pens Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Smart Insulin Pen 7.2. Adaptors for Conventional Pen 8. Global Smart Insulin Pens Market, By Connectivity Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Bluetooth 8.2. USB 9. Global Smart Insulin Pens Market, By Diabetes Type Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Type 1 Diabetes 9.2. Type 2 Diabetes 10. Global Smart Insulin Pens Market, By Distribution Channel Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Hospital Pharmacy 10.2. Online Sales 10.3. Retail Pharmacy 10.4. Diabetes Clinics/Centres 11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) along with expected regulatory needs 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2020-2027 12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) - along with expected regulatory needs 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 14. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Regional Market Trends 14.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.3.1. Brazil 14.3.2. Venezuela 14.3.3. Argentina 14.3.4. Rest of Latin America 14.4. Market Size (USD Million) Forecast for Latin America 2020-2027 15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2020-2027 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 16.1. Novo Nordisk 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Sanofi 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Eli Lilly and Co. 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Companion Medical 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Emperra GmbH E-Health Technologies 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Diabnext 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Jiangsu Delfu Medical Device Co. Ltd. 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Berlin Chemie 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Diamesco Co. Ltd. 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10. Patients Pending Ltd. 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 17. FutureWise SME key takeaway points for Client
1. Market Introduction
1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered
1.4 Currency 1.5 Limitations 1.6 Stakeholders
2. Research Methodology
2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study
3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Smart Insulin Pens Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards And Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Smart Insulin Pens Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Smart Insulin Pens Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Smart Insulin Pen 7.2. Adaptors for Conventional Pen 8. Global Smart Insulin Pens Market, By Connectivity Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Bluetooth 8.2. USB 9. Global Smart Insulin Pens Market, By Diabetes Type Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Type 1 Diabetes 9.2. Type 2 Diabetes 10. Global Smart Insulin Pens Market, By Distribution Channel Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Hospital Pharmacy 10.2. Online Sales 10.3. Retail Pharmacy 10.4. Diabetes Clinics/Centres 11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) along with expected regulatory needs 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2020-2027 12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) - along with expected regulatory needs 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 14. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Regional Market Trends 14.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.3.1. Brazil 14.3.2. Venezuela 14.3.3. Argentina 14.3.4. Rest of Latin America 14.4. Market Size (USD Million) Forecast for Latin America 2020-2027 15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2020-2027 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 16.1. Novo Nordisk 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Sanofi 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Eli Lilly and Co. 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Companion Medical 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Emperra GmbH E-Health Technologies 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Diabnext 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Jiangsu Delfu Medical Device Co. Ltd. 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Berlin Chemie 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Diamesco Co. Ltd. 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10. Patients Pending Ltd. 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 17. FutureWise SME key takeaway points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics